These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 18835379

  • 21. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [Abstract] [Full Text] [Related]

  • 22. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
    Kim HJ, Woo IS, Kang ES, Eun SY, Kim GH, Ham SA, Kim HJ, Lee JH, Chang KC, Kim JH, Lee HT, Seo HG.
    Biochem Biophys Res Commun; 2006 Oct 20; 349(2):660-7. PubMed ID: 16945329
    [Abstract] [Full Text] [Related]

  • 23. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB, Miron P, Miron A, Iglehart JD.
    J Surg Res; 2007 Mar 20; 138(1):37-44. PubMed ID: 17109887
    [Abstract] [Full Text] [Related]

  • 24. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD, Sun JZ, Bi DS, Ma R.
    Ai Zheng; 2003 Apr 20; 22(4):376-9. PubMed ID: 12703992
    [Abstract] [Full Text] [Related]

  • 25. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L, Dai Y, Gu Q, Chan KW, Ma J, Lan HY, Zou B, Rocken C, Ebert MP, Wong BC.
    Cancer Lett; 2008 Sep 18; 268(2):260-71. PubMed ID: 18477501
    [Abstract] [Full Text] [Related]

  • 26. The combination of green tea and tamoxifen is effective against breast cancer.
    Sartippour MR, Pietras R, Marquez-Garban DC, Chen HW, Heber D, Henning SM, Sartippour G, Zhang L, Lu M, Weinberg O, Rao JY, Brooks MN.
    Carcinogenesis; 2006 Dec 18; 27(12):2424-33. PubMed ID: 16785249
    [Abstract] [Full Text] [Related]

  • 27. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M, Saigo K, Nakamachi Y, Kawano S, Hashimoto M, Fujioka T, Koizumi T, Tatsumi E, Kumagai S.
    Acta Haematol; 2006 Dec 18; 116(1):30-40. PubMed ID: 16809887
    [Abstract] [Full Text] [Related]

  • 28. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 18; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 29. The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.
    Czeczuga-Semeniuk E, Jarzabek K, Lemancewicz D, Wołczyński S.
    Gynecol Endocrinol; 2009 May 18; 25(5):287-93. PubMed ID: 19340624
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
    Motomura W, Nagamine M, Tanno S, Sawamukai M, Takahashi N, Kohgo Y, Okumura T.
    J Gastroenterol; 2004 May 18; 39(5):461-8. PubMed ID: 15175945
    [Abstract] [Full Text] [Related]

  • 31. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins.
    Planas-Silva MD, Hamilton KN.
    Cancer Chemother Pharmacol; 2007 Sep 18; 60(4):535-43. PubMed ID: 17186241
    [Abstract] [Full Text] [Related]

  • 32. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.
    Girault I, Bièche I, Lidereau R.
    Maturitas; 2006 Jul 20; 54(4):342-51. PubMed ID: 16822624
    [Abstract] [Full Text] [Related]

  • 33. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR, Allred CD, Zaytseva YY, Kilgore MW.
    Breast Cancer Res Treat; 2008 Mar 20; 108(1):23-33. PubMed ID: 17453334
    [Abstract] [Full Text] [Related]

  • 34. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 20; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 35. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
    Lee JE, Chung KW, Han W, Kim SW, Kim SW, Shin HJ, Bae JY, Noh DY.
    Anticancer Res; 2004 Oct 20; 24(6):3961-4. PubMed ID: 15736439
    [Abstract] [Full Text] [Related]

  • 36. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
    Wang Y, He QY, Chen H, Chiu JF.
    Exp Cell Res; 2007 Jan 15; 313(2):357-68. PubMed ID: 17098229
    [Abstract] [Full Text] [Related]

  • 37. Estradiol and tamoxifen differently affects the inhibitory effects of vitamin A and their metabolites on the proliferation and expression of alpha2beta1 integrins in MCF-7 breast cancer cells.
    Czeczuga-Semeniuk E, Lemancewicz D, Wołczyński S.
    Adv Med Sci; 2009 Jan 15; 54(1):91-8. PubMed ID: 19581203
    [Abstract] [Full Text] [Related]

  • 38. Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
    Horner-Glister E, Maleki-Dizaji M, Guerin CJ, Johnson SM, Styles J, White IN.
    J Mol Endocrinol; 2005 Dec 15; 35(3):421-32. PubMed ID: 16326830
    [Abstract] [Full Text] [Related]

  • 39. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y, Ito I, Wayama M, Fujimura A, Akaogi K, Machida H, Nakajima Y, Kuroda T, Ohmori K, Murayama A, Kimura K, Yanagisawa J.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):145-8. PubMed ID: 18355447
    [Abstract] [Full Text] [Related]

  • 40. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H, Pan X, Qi H, Wang X, Hou S, Han B, Liu Z, Xu L.
    Oncol Rep; 2011 Jan 23; 25(1):81-90. PubMed ID: 21109961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.